Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma

Fig. 3

Clinical variable comparisons and validation of the predictive performance of the CDI signature. (A) Comparison of the percentage of different age and subtypes of LUSC between high- and low-risk groups by Fisher’s exact test in the TCGA-LUSC cohort. (B) The median value and distribution of the risk scores of CDI signature in the GSE74777 cohort. (C) Kaplan-Meier survival analysis of the CDI signature of LUSC patients in the GSE74777 cohort

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us